GNH USA

Europe — EMA

Levodopa + Carbidopa + Entacapona Ratiopharm (Carbidopa, Entacapone, Levodopa)

GNH USA supplies Levodopa + Carbidopa + Entacapone Ratiopharm (Levodopa/Carbidopa/Entacapone), a dopamine precursor and COMT inhibitor combination

Carbidopa, Entacapone, Levodopa

Request sourcing

1
Pack/s

What is Carbidopa, Entacapone, Levodopa?

Levodopa, Carbidopa, Entacapone, the active ingredient in Levodopa + Carbidopa + Entacapone Ratiopharm, is a dopamine precursor and COMT inhibitor combination presented as oral tablets for oral use. It treats Parkinson's disease and motor fluctuations in patients with Parkinson's disease, providing continuous dopaminergic stimulation and improving motor control.

GNH USA supplies Levodopa + Carbidopa + Entacapone Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Carbidopa, Entacapone, Levodopa used for?

Levodopa/Carbidopa/Entacapone is used in the management of Parkinson's disease, targeting dopaminergic pathways to improve motor function. - Parkinson's disease: improves overall motor symptoms and rigidity. - Motor fluctuations in Parkinson's disease: reduces OFF periods and smooths response to levodopa. - Advanced Parkinson's disease: enhances dopaminergic stimulation for better daily functioning.

What are the side effects of Carbidopa, Entacapone, Levodopa?

Levodopa/Carbidopa/Entacapone may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: especially on standing, due to orthostatic changes. - Dry mouth: reduced salivation. - Headache: transient cranial discomfort. - Orthostatic hypotension: drop in blood pressure upon standing. - Vomiting: occasional severe nausea leading to emesis.

Serious or Rare Side Effects: - Dyskinesia: involuntary movements with prolonged use. - Hallucinations: visual or auditory disturbances. - Severe hypotension: marked blood pressure fall requiring medical attention. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Depression or suicidal thoughts: mood changes requiring monitoring.

What precautions apply to Carbidopa, Entacapone, Levodopa?

When prescribing Levodopa/Carbidopa/Entacapone, clinicians should observe several safety measures. - Monitor blood pressure: watch for orthostatic hypotension, especially after dose initiation. - Assess liver function: entacapone may affect hepatic enzymes; periodic testing is advised. - Evaluate psychiatric status: risk of hallucinations or mood changes in susceptible patients. - Adjust dose in renal impairment: use caution and consider dose reduction. - Avoid use in patients with known hypersensitivity to any component. - Store at ambient temperature: keep in the original pack, protect from moisture.

What does Carbidopa, Entacapone, Levodopa interact with?

Levodopa/Carbidopa/Entacapone can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - MAO‑B inhibitors: risk of hypertensive crisis. - Non‑selective MAO inhibitors: severe hypertension may occur. - Iron supplements: reduce levodopa absorption, diminishing efficacy.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may mask levodopa side effects. - Antidepressants (SSRIs, SNRIs): increase risk of serotonin syndrome. - Antihypertensive drugs: additive blood‑pressure lowering effect.

Frequently asked questions

What is Levodopa + Carbidopa + Entacapone used for?+
Levodopa + Carbidopa + Entacapone is prescribed to manage Parkinson's disease and to reduce motor fluctuations in patients who experience periods of reduced symptom control, known as OFF episodes. It works by increasing dopamine levels in the brain and prolonging the effect of levodopa.
How does the combination of levodopa, carbidopa, and entacapone work?+
Levodopa is a dopamine precursor that crosses the blood‑brain barrier and is converted to dopamine. Carbidopa blocks peripheral conversion of levodopa, allowing more to reach the brain. Entacapone inhibits the COMT enzyme, slowing levodopa breakdown outside the brain, which extends its therapeutic action.
What is the usual dose of Levodopa + Carbidopa + Entacapone?+
The specific dose and dosing schedule are determined by the prescribing clinician based on the individual’s disease stage, response to therapy, and other medical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Levodopa + Carbidopa + Entacapone safe during pregnancy or breastfeeding?+
Safety data for use in pregnancy and lactation are limited, and the product’s pregnancy category is unknown. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.
How do I order Levodopa + Carbidopa + Entacapone from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does this product compare with other Parkinson's disease treatments?+
Levodopa/Carbidopa/Entacapone combines a dopamine precursor with a peripheral decarboxylase inhibitor and a COMT inhibitor, offering more stable levodopa levels than levodopa alone. Compared with other formulations, it may reduce OFF time and improve motor control without requiring additional dosing frequency.
What are the storage and handling requirements for this medication?+
The tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep them out of reach of children and do not use them after the expiration date.
How is Levodopa + Carbidopa + Entacapone administered?+
The medication is taken orally, usually with food or as directed by the prescriber to minimize gastrointestinal discomfort. Tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.
What are the most serious risks associated with this drug?+
Serious risks include dyskinesia (involuntary movements), severe hypotension, hallucinations, neuroleptic malignant syndrome, and rare allergic reactions such as anaphylaxis. Patients should be monitored regularly for these events, and any concerning symptoms should be reported promptly.
Who should not use Levodopa + Carbidopa + Entacapone?+
Individuals with known hypersensitivity to levodopa, carbidopa, entacapone, or any excipients should avoid this medication. It is also contraindicated in patients taking non‑selective MAO inhibitors or those with severe hepatic impairment without careful medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Carbidopa, Entacapone, Levodopa
Route
Oral Use
Manufacturer
Ratiopharm-Comercio E Industria De Produtos Farmaceuticos Lda
Origin
EU

Related products

Carbidopa-Entacapone-Levodopa Teva

Carbidopa-Entacapone-Levodopa Teva

Carbidopa, Entacapone, Levodopa

Teva Italia S.R.L.
EU
Corbilta

Corbilta

Carbidopa, Entacapone, Levodopa

Orion Corporation
EU
Corbilta

Corbilta

Carbidopa, Entacapone, Levodopa

Orion Corporation
EU
Corbilta

Corbilta

Carbidopa, Entacapone, Levodopa

Orion Corporation
EU